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Sub-Saharan Africa is generally depicted as the region with
fewest IVF clinics compared to all other regions worldwide
(Inhorn and Patrizio, 2015). Within the region, South Africa,
Nigeria and Ghana are referred to as ‘comparative regional
success stories’ (Inhorn and Patrizio, 2015: 6). Nigeria was
the first sub-Saharan African country to open an IVF clinic, in
1984 (Giwa-Osagie, 2002). In Ghana, the country on which
this article focuses, the first IVF baby was born in 1995. Since
then, a growing number of IVF clinics in Ghana – all private –
have been offering IVF and other high-tech assisted
reproductive technologies. To date, however, the country’s
public health sector is not involved at all in its provision.
Moreover, the field of infertility and assisted reproductive
technologies functions without any form of financial support
from international health or development organizations
(Hörbst and Wolf, 2014; Inhorn and Patrizio, 2015).
Yet the establishment and actual functioning of IVF
clinics in Ghana is far from a local enterprise. On the
contrary, in many ways the Ghanaian IVF industry is a highly
transnational undertaking, involving an ongoing cross-border
and even cross-continental flow of people, technologies,
skills, knowledge and ideas. Most explanations of transna-
tional mobility of people in Africa have focused on economic
inequalities between sending and receiving places (cf. Dilger
et al., 2012). This case study of the establishment of IVF in
Ghana draws attention to multiple forms and directions of
transnational mobility – from and to Africa – and its focus
is certainly not on the destitute or less privileged social
strata (cf. Hörbst, 2010). The current article thus addresses
not only the origins and development of IVF in Ghana
(constituting repro-nationalism), but also sheds light on
repro-transnationalism.
After Louise Brown – the world’s first ‘test-tube baby’ –
was born in England in 1978 via IVF, this reproductive
technology soon spread throughout North America and
Western Europe, as well as to the continent of Australia.
The rapid development of IVF worldwide over the past three
decades has led not only to its expansion, but also to an
enormous diversification. This Symposium Issue aims to
assess the global histories of IVF, analysing the rapid but
very uneven global diffusion of one of the world’s most
important reproductive technologies. The current article
aims to provide an insight into the particularities of the
uptake of these technologies in Ghana, which was one of the
first African countries to offer them.
The article is based mainly on ethnographic research
that I carried out in 2012 and 2013 in two private clinics in
Ghana offering assisted reproductive technologies (see
Hörbst and Gerrits (2015) for more details about the study
methodology). Ethical clearance for the study was obtained
from the Noguchi Memorial Institute for Medical Research-IRB
in Accra, Ghana.
The article addresses the transnational connections
and networks of African assisted reproductive technology
providers – and users – and their vital importance for the
establishment and continuing functioning of local IVF clinics.
These multiple transnational connections and interactions
co-shape the local appropriation and actual supply and
use of assisted reproductive technologies in Ghana to a
certain extent; yet at the same time, country-specificcircumstances and values also affect the local appropriation
of assisted reproductive technologies (cf. Gerrits and
Hörbst, 2016; Hörbst and Gerrits, 2015) and also inform the
recently heard concerns about the use of donor material and
surrogacy. Recently, a new form of transnational connection
and collaboration in the field of assisted reproductive
technologies has been initiated in Ghana, seeking to
introduce more affordable IVF to the country, an initiative
that will also be discussed below.The origin and development of IVF in Ghana
Training abroad and private initiatives
The first successful IVF procedure in Ghana was conducted in
1995 in a private clinic, the Pro Vita Specialist Hospital
(further referred to as Pro Vita Hospital), in Tema, a harbour
town close to the capital city Accra. Dr Mainoo, the founding
director of the clinic, left Ghana in 1963 to study medicine in
Germany, where he also specialized in gynaecology and
worked for many years as a specialist. In 1982, he returned
to Ghana with the plan of setting up a private gynaecology
clinic, investing the money he had earned in Germany. Back
in Ghana, he found himself faced with many cases of
infertility and it was only then he realized that infertility
was a major reproductive health problem in his country –
both in terms of numbers as well as concerning the impact it
had on the women and men concerned – and thus required
specialized attention. As he had not previously trained in the
use of IVF, he returned to Germany several times and, using
his old professional network, further specialized in IVF. In
1995, he was able to carry out the first successful IVF
procedure in his own clinic, giving him the status of Ghana’s
IVF pioneer.
Since Dr Mainoo began providing IVF in the mid-1990s,
several other clinics in the country have started offering
assisted reproductive technologies, mainly in the southern
region, in or not far away from the capital city Accra, but
more recently also in the centre of the country (in Kumasi).
As of 2015, 14 clinics, all of them private, are offering
assisted reproductive technologies; some solely focus on the
treatment of infertility, while others provide a broader
scope of medical specialties (information provided by Nana
Yaw Osei, the founder of the Association of Childless Couples
of Ghana – ACCOG). One of these latter clinics is Lister
Hospital and Fertility Centre (further referred to as Lister
Clinic), the second private clinic (in addition to Pro Vita
Hospital) where I conducted my research. The founding
director of this clinic, Dr Hiadzi, started his medical training
in Ghana, qualifying in 1982, followed by postgraduate
training in Glasgow, Scotland, qualifying in 1992. After his
return to Ghana, he worked in a hospital in Accra, where in
1996 he initiated intrauterine insemination (IUI) fertility
treatments. He then realized that there was a huge demand
for more advanced reproductive treatments, which led him
to return to the UK to do a specialization in IVF and other
assisted reproductive technologies, this time at King’s
College Hospital, London. He went there together with an
embryologist and a nurse; all three had the intention of
training in assistive reproductive technologies in order to be
able to offer them together as a team. Dr Hiadzi and the
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private clinic and together they started providing IVF in
2004. The nurse has to date not returned to Ghana, so
Dr Hiadzi has to work with nurses with no specialized
assisted reproductive technology training. Furthermore, the
embryologist left the clinic suddenly in 2011, which placed
it in a precarious situation. Well-trained embryologists
specialized in fertilization are indispensable for a fertility
clinic’s proper functioning. They are, however, extremely
scarce on the African continent.
The scarcity of embryologists
Guaranteeing ongoing and high-quality embryology knowledge
and laboratory skills constitutes one of the major challenges
for both of the clinics. Both have been confronted with
embryologists (suddenly) leaving their jobs towork elsewhere.
To resolve the problem of the sudden departure of the
embryologist at the Lister Clinic in 2011, Dr Hiadzi contracted
a British embryologist, who began working at the clinic for one
week on a more or less monthly basis; women’s treatment
cycles were adapted to these monthly visits. When this
embryologist was in the clinic, he performed the lab work for
the couples in treatment and provided on-the-job training for
two Ghanaian staff members working at the IVF laboratory.
This British embryologist had been working overseas since the
1990s. Similar constructions of collaboration with embryolo-
gists were observed by Viola Hörbst in her work in Uganda, as a
way to resolve the scarcity of embryologists (Hörbst and
Gerrits, 2015).
Guaranteeing embryology expertise has also been a
challenge for the Pro Vita Hospital. In 1995, Dr Mainoo
started out with a Ghanaian embryologist who had been
trained in Germany, although he left the clinic after 3 years.
Since then, Dr Mainoo has been working with and has
invested in four other embryologists. The lab technician
working at the Pro Vita Hospital during the period in which I
conducted the research – a smart and ambitious young
man – was trained in Germany and on the job in Ghana (with
the help of an Iranian embryologist residing in Germany, who
came once a year to assist at the Pro Vita Hospital), and took
various training courses, including at the yearly European
Society of Human Reproduction and Embryology (ESHRE)
conferences, from the World Health Organization (WHO) in
South Africa and from the European industrial companies
that delivered laboratory equipment to the clinic. In 2013,
he completed his Master’s in Clinical Embryology in the UK,
which he had financed himself. The impact of the transna-
tional networks, collaborations and training activities in
the area of embryology, in terms of the treatment and
laboratory regimes applied in clinics, has been addressed
elsewhere (Hörbst and Gerrits, 2015).
Other forms of transnational collaboration
In addition to transnational cooperation with embryologists
based in Europe, the Lister Clinic also collaborated with a
clinic in the UK, in particular when donor material was being
used, and some elements of the treatment were conducted in
two different places (this refers to the practice of cross-border
treatment and reproductive travelling that I discuss below).Dr Hiadzi intended to intensify his collaboration with this UK
clinic in order to offer preimplantation genetic diagnosis
(PGD), mainly in order to detect cases of sickle cell disease, a
common genetic condition among ‘Africans’. Finally, the
Lister Clinic occasionally collaborated with a South African
clinic for genetic testing (karyotyping).
All materials used in both clinics – equipment, laboratory
agents and medicines – had to be imported, mostly from
European companies and occasionally also from American
ones, some of which had a representative in Ghana. Thus in
terms of materials as well as specialized training and
expertise, both clinics depended hugely on input from
Europe and – to a lesser extent – the USA and South Africa.International standards and local practices
Staff from both clinics attended international conferences,
in particular those of the ESHRE, but occasionally also those
of the American Society for Reproductive Medicine (ASRM).
In addition, the clinics subscribed to Human Reproduction
and Fertility and Sterility, the two most influential
European- and American-based professional journals in the
field, respectively. They were thus well informed about
innovations in the field and aware of debates on the
constantly changing ‘international standards’ in IVF. While
clinic staff definitely followed several of these standards,
they also set their own local practices and procedures, for
example regarding the maximum number of embryos to be
transferred, which was usually higher than the number of
embryos recommended by the above-mentioned profession-
al associations at the time (Hörbst and Gerrits, 2015). To
date, there are no assisted reproductive technology legisla-
tion or professional guidelines in Ghana, which allows the
clinic directors to set their own rules and treatment
regimes, in terms of both ethics and technology. The lack
of such regulations turns the clinic doctors into ‘moral
pioneers’ – a concept introduced by Rayna Rapp to refer to
women who had to decide whether or not to terminate their
pregnancies on the basis of amniocentesis results (Rapp,
1999) – as well as entrepreneurs (Gerrits and Hörbst, 2016).
Thus, while transnational connections, as depicted above,
have had an impact on the way in which assisted reproduc-
tive technologies are delivered in the studied clinics, several
local practices were noted, showing the limits of these
influences in daily practice (Hörbst and Gerrits, 2015).
One of the striking ‘local practices’ that I encountered in
the Ghanaian clinics was the (extended) period of bed rest
prescribed after embryo transfer. In the Lister Clinic,
women were strongly recommended to remain hospitalized
for 5 days after the embryo transfer, while in the Pro Vita
Hospital, hospitalization after the embryo transfer was
mandatory for all women, at least up to the pregnancy
test, during which time they were advised to remain in bed
and move as little as possible. Furthermore, women at the
Pro Vita Hospital who tested positive were strongly recom-
mended to remain hospitalized up to the confirmation of
pregnancy by foetal ultrasound (conducted 2–3 weeks after
the initial pregnancy test). In addition, depending on a
number of conditions, several women were strongly advised
to stay in the clinic for up to 3 or 4 months of their
pregnancy, or even until delivery (which was a Caesarean
35Assisted reproductive technologies in Ghanasection in most cases). While the procedures following the
embryo transfer differed substantially in the two clinics, the
doctors basically used the same reasoning to justify their
recommendations – they pointed to the bad road conditions
in Ghana and to the fact that the pregnancy created was
‘precious’ (both culturally and financially) because most of
the couples had to pay for the IVF themselves. The fact that
many women had to travel long distances – coming from
abroad or from far away in the country – and thus could not
easily return for follow-up visits, constituted another
argument for their prolonged hospitalization (particularly
in the Pro Vita Hospital). This was backed up by Dr Mainoo’s
argument that possible complications resulting from the IVF
might not be recognized by other doctors. As a result of such
procedures, the wards at the Pro Vita Hospital were full of
pregnant women; during my first fieldwork visit, around
30–40 pregnant women were hospitalized. Hospitalization
after the embryo transfer clearly added to the costs of
treatment. While several women (particularly in the Pro Vita
Hospital) complained about this long (and boring) period
of hospitalization and the extra costs it entailed, and
questioned whether it was really necessary, others
commented that the opportunity to stay longer in the
hospital gave them a sense of security and was exactly the
reason they had chosen this hospital.
The embryo transfer was just one of many steps of an IVF
cycle to be conducted in a particular way in these two
Ghanaian clinics. This particular ‘local appropriation’ of IVF
reflects local values and circumstances, underlining the
notion that local factors may ‘reshape and sometimes
curtail’ the way in which assisted reproductive technologies
are used in particular localities (Inhorn, 2003: 16) and
confirming the fact that technologies undergo local trans-
formations and appropriation – for socio-material reasons –
when travelling from the places where they are initiated (in
‘the West’) to other contexts (Hadolt et al., 2012). The local
appropriation of assisted reproductive technologies is a topic
that deserves more scholarly attention, as it can further our
understanding of the societies and cultures in which assisted
reproductive technologies are embedded and employed, as
well as of the local meanings, experiences and impacts of
the use of assisted reproductive technologies.Assisted reproductive technologies, third-party
involvement and costsSince the opening of these two clinics, the number and type
of treatments that they offer have steadily increased. Both
clinics in principle offer IUI, IVF and intracytoplasmic sperm
injection (ICSI), while the Lister Clinic occasionally also
offers testicular sperm extraction (TESE) and percutaneous
epididymal sperm aspiration (PESA). In practice, however,
the Pro Vita Hospital was conducting very few IUIs and ICSIs:
IUI was not considered an effective treatment for most of
the couples attending the clinic (given the high prevalence
of bilateral tubal block), and ICSI was only provided when
the Iranian embryology specialist visited the clinic (once a
year); the Ghanaian embryologist knew how to do ICSI, but
had too little hands-on experience to guarantee its proper
and successful use.Both clinics also offered treatments using donor material
and surrogates. No information was available about the
number of treatments being conducted that involved donor
material and/or surrogacy, but it (in particular oocyte
donation) constituted a substantial part of the total
treatments conducted. Egg donation exceeded sperm dona-
tion, and egg sharing was a common practice; in particular,
the ova provided by egg donors were frequently used by two
or more couples. The relatively high demand for surrogacy
may be explained by the fact that many women only come
to the clinic at a later age, when their own capacity to
conceive and carry a child has greatly reduced. All donation
and surrogacy was anonymous and none of the women (and
men) I spoke with intended to share the fact that they had
employed these methods of conception with others (includ-
ing their offspring); it would be their well-kept secret.
When the Pro Vita Hospital began to involve third parties in
procreation, it performed all of the related non-medical tasks
itself – finding, screening, informing and contracting donors
and surrogates and organizing the related legal procedures.
However, from 2013 onwards the clinic started to make use of
intermediary agencies to arrange these non-medical aspects.
The Lister Clinic, on the contrary, used the services of an
intermediary agency from the moment they began working
with surrogates, although clinic staff select and screen donors
themselves. The first intermediary agency in Ghana was set up
by a Ghanaianwomanwho had lived in the USA for many years.
As she could not find an appropriate surrogate in the USA, she
returned to Ghana where she first organized a surrogate for
herself (according to her, this was the first time surrogacy had
ever been done in the country) and subsequently she was
requested by ‘her gynaecologist’ to arrange surrogates for
others as well, which led to the creation of her agency in 2004
(Gerrits and Hörbst, 2016). Since then other intermediaries
have followed.
The number of IVF cycles performed in the Pro Vita
Hospital reached its peak in 2005–2008, when over 800 IVF
cycles were conducted on a yearly basis. Since then, the
patient load has started to decrease: in 2012, 630 IVF cycles
were conducted, which – according to the clinic director –
was probably due to the increasing number of IVF clinics in
Ghana. The total number of cycles conducted at the Lister
Clinic has been consistently much lower: in 2010, the clinic
conducted 102 IVF/ICSI cycles, and in 2011 there were 222
IUIs. In Ghana, there is no central registration of the number
of cycles performed per clinic.
Treatment costs were around 2500 euros per IVF cycle
(without use of donor material or surrogacy). This was the
amount of money for a ‘natural IVF cycle’ in the Lister Clinic
(as mentioned in the tariffs list), and did not include
examinations, medicines, hospitalization and other costs. I
do not have such a tariffs list for the Pro Vita Hospital, but
from the women in treatment I understood that it was a
similar amount of money. Yet, as previously stated, the
long-term stay in the clinic added a substantial sum of
money to the costs of IVF.
Most users have to cover treatment expenses themselves.
Only a few can get (part of) the treatment costs reimbursed
by their private health insurance (this mainly applies to
people who have health insurance offered by the private
[international] company they work for). This implies that, as
in most other resource-poor countries, assisted reproductive
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happy few, leading to an extreme form of ‘stratified
reproduction’, a concept first used by Sarah Colen, referring
to the idea that some people, because of cultural and/or
structural factors, are more empowered to reproduce than
others (Colen, 1995; Ginsburg and Rapp, 1995). Many
assisted reproductive technology users in the clinic were
well off, highly educated and often owned or worked in
private companies. Less affluent women and men do attend
these clinics to undergo IVF cycles as well, but this is only
possible after spending a long time saving up, selling
commodities, taking out bank loans and/or accepting
support from relatives.Transnational usersAside from attracting women and men from all over Ghana,
both of the clinics in which I conducted fieldwork also
attracted many clients from neighbouring West African
countries such as Gabon, Nigeria, Ivory Coast and Burkina
Faso. In addition, Ghanaian people living in the diaspora in
the USA and Europe return home for IVF cycles (cf. Inhorn,
2011). These cross-border and return reproductive travellers
have various reasons for doing so. Many of those with whom I
spoke – especially those coming from the region – were
attracted by the good reputations of the clinics. In
particular, the doctor at the Pro Vita Hospital had built up
a strong reputation in Ghana as a successful IVF pioneer. The
reputation of both clinics seemed to be very much based on
the spread of success stories, some of which were highlight-
ed in local newspapers and on the internet, but in particular
through word of mouth. Most women had no idea of the
actual success rates of the clinics, and had not even asked
for them. For most, hearing success stories – or actually
seeing babies born as a result of IVF in these clinics – was an
important reason for visiting their clinic of choice (this
applied also to the women and men residing in Ghana).
Hardly any of these couples were interested in statistics (cf.
Paxson, 2006), and most did not act as the critical and
well-informed consumers that many assisted reproductive
technology users in the West are portrayed as being (see e.g.
Gerrits, 2014, 2016).
Indeed, it would be accurate to say that the criteria on
which clinic performance was assessed were quite different in
Ghana compared with the West, and overall the exchange of
information – not only about success rates – during consulta-
tion hours in the two clinics was often very limited. However,
assisted reproductive technology users did have regular
contact with clinic staff in other ways. For example, the
nurse at the Lister Clinic could be telephoned day and night
and many clients (from abroad) had email contact with the
clinic director before actually visiting the clinic. Patient–staff
interactions, the provision, requirement and use of informa-
tion, informed consent procedures and counselling practices
in the studied clinics were thus differently shaped – and
maybe also differently appreciated by their users – in this
context of transnational assisted reproductive technology
consultations, and where consultation hours are busy and the
social distance between clinic staff and part of the assisted
reproductive technology users may be large.In addition to the clinics’ good reputations, there were
several other motivations – push and pull factors – for women
andmen to cross borders to visit these Ghanaian IVF clinics (cf.
Inhorn and Gürtin, 2011; Inhorn and Patrizio, 2012). Push
factors were related to the situation in their country of
residence, such as legal or ethical prohibitions, high costs of
assisted reproductive technologies, or complete lack or
shortage of services. Pull factors were related to the situation
in Ghana, such as being surrounded by supporting relatives,
the availability of matching donor material and surrogates,
and ‘patriotic pride’ (cf. Inhorn, 2011).
No figures are available about the magnitude of cross-
border reproductive travel to Ghana. Yet the seemingly high
level of transnational reproductive mobility across West
African borders may reflect the high overall transnational
mobility in the region, mainly for commercial reasons. In
addition, return reproductive travel may be a reflection of the
high number of Ghanaian citizens living in the diaspora,
estimated at around 1 million, of which one-third is based in
the USA, one-third in the UK and the other third in other
European countries (Orozco et al., 2005). Part of this migrant
population is presumably well educated and potentially
earning a good enough income to afford transnational travel
and IVF expenses. For example, data presented by the
International Organisation for Migration (IOM) show that in
the health sector alone, over 12,000 well-educated profes-
sionals left Ghana in the period between 1993 and 2002,
including 630 doctors, 410 pharmacists, 87 laboratory techni-
cians and 11,325 nurses. Furthermore, 50% of all medical
school graduates in the country emigrate within 4.5 years
(IOM, 2005).Societal concerns
While the initial introduction of ‘traditional IVF’ did not lead
to too much societal concern in Ghana, the more recent and
increasing use of third-party involvement in conception did
raise questions about its acceptability, both on the part of
the Ghanaian government and the Pentecostal Church. The
government – in the person of the Minister of Gender,
Children and Social Protection – has announced the need to
regulate the practice of gamete selling, of which she said,
‘Of course, it’s legitimate, but there are implications too’
(Anonymous, 2013). Proper regulation is intended to lessen
the negative impact that the practice could potentially have
on society, and in particular on the ‘children to be
produced’. One of the concerns expressed – or ‘moral
panics’ (cf. Carsten, 2004), which can be defined as feelings
of fear spread among a large number of people that some
evil threatens the well-being of society – is that children
conceived with the same donor material might later marry
and have children together, which ‘raises issues of morality
and ethics’.
In the same period as the government’s intervention on
the issue, the Executive Council of the Church of Pentecost
presented its view on third-party involvement in conception,
fully condemning it and starting from the position that, ‘The
Church believes that physical intimacy between a husband
and wife remains the biblical means of producing children’
(Executive Council of the Church of Pentecost, 2012).
Couples are, nevertheless, allowed to use assisted
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material. The Pentecostal Church also took a strong position
against discarding frozen embryos, as this would mean that
human life would be destroyed, which would be ‘tantamount
to abortion’. To avoid the discarding of embryos, and in case
of a need to freeze gametes, the church stipulated that eggs
and sperm should be frozen separately (and thus not
embryos). While the state and the Pentecostal Church are
thus starting to consider their positions vis-à-vis third-party
involvement in conception, in the present-day Ghanaian
context – where there is no form of assisted reproductive
technology legislation or professional guidelines – clinic
directors are to a large extent free to decide how they
perform assisted reproductive technologies (cf. Hörbst and
Gerrits, 2015).
New transnational connections – ‘more
affordable’ IVF in Ghana
Finally, there is a recent development in the field of assisted
reproductive technologies in Ghana, namely the introduction
of ‘more affordable’ IVF, sometimes referred to as low-cost IVF
(LCIVF) (Inhorn and Patrizio, 2015). The LCIVF movement has
been characterized as ‘a reproductive justice movement,
driven by the goal of helping the world’s infertile, most of
whom are located in resource-poor settings’ (Ibid. and 20: 9).
One of the organizations involved in this movement is the
Walking Egg (tWE), a non-profit organization initiated by the
Belgian gynaecologist Willem Ombelet (see e.g. Ombelet,
2014). One aim of the organization is the development of a
simplified laboratory method for IVF, which avoids the use of –
and thus high-cost investment in – specialized laboratory
equipment (the tWE method is explained in Johnson et al.
(2014) and Van Blerkom et al. (2014)). This new laboratory
method, referred to as tWE-IVF, has recently been tested in a
pilot clinical trial in Belgium,which showed encouraging results
(Johnson et al., 2014; Ombelet, 2014; Van Blerkom et al.,
2014). The next step is to introduce this new laboratorymethod
in a number of African countries, including Kenya and Ghana.
Ghana has become one of the first sites to work with this
new, more affordable, tWE method, as a result of the efforts
of Naya Yaw Osei, the founder and director of the first
Association of Childless Couples of Ghana (ACCOG), set up in
2013. The aim of ACCOG is threefold: to support, inform and
counsel childless couples; to decrease their stigmatization;
and to increase affordable and accessible high-tech treat-
ment options in the country. When Osei learned about the
tWE-IVF initiative via the internet he sought contact with
tWE and became determined to introduce this new and more
affordable IVF technology to Ghana. Subsequently, he has
convinced the Ghanaian Church of Pentecost to set up a
private fertility clinic in Accra, in which tWE-IVF will be
offered. The price of tWE-IVF in the Ghanaian context is
estimated to be around 1000–1500 Euros per IVF cycle,
including expenses for infrastructure, staff costs and
medication. As this is almost less than half the price of
traditional IVF in Ghana, it will make IVF more accessible to
and affordable for a larger group of Ghanaian citizens (but
definitely not for all), and as such will modify the existing
pattern of stratified reproduction regarding the use of
assisted reproductive technologies. tWE has invested in thetraining of laboratory technicians and doctors, both in
Belgium and Ghana, to enable them to perform the new
(laboratory) methods. Yet, as even the low-cost tWE
procedures demand an initial financial investment in
laboratory infrastructure (which tWE does not support), its
actual implementation will not start before this financial
obstacle has been successfully overcome.ConclusionThe above is a sketch of the origins and development of IVF in
Ghana, with special attention to the multiple forms and
directions of transnational mobility and flows, which are
indispensable for the functioning of the Ghanaian IVF industry.
These movements are from and to Africa, often involve human
beings, but also refer to other entities such as technologies,
skills and knowledge. It is striking that none of these
movements are paid for using public (Ghanaian) money, nor
are they subsidized by international health organizations, a
pattern that is in strong contrast to the way in which many
other (reproductive) health issues in Africa are addressed and
financed. This financial independence enables clinic directors
to be rather autonomous decision-makers regarding their
clinical and ethical practices (Hörbst and Gerrits, 2015).
Also salient is the fact that training in this specialized
field of assisted reproductive technologies – both the
clinical and embryological part – is not offered in Ghana,
which means that embryologists’ expertise and skills in
particular are a scarce and precious commodity. Despite
almost seven decades of independence after colonization –
Ghana became independent from the UK in 1957 – the
Ghanaian local assisted reproductive technology industry
cannot function without this new ‘neocolonial dependency’,
which is most outspokenly reflected by the fact that
international embryologists have to fly into the country to
enable the performance of IVF.
Furthermore, the transnational reproductive travellers –
women and men from neighbouring countries and Ghanaians
in the diaspora returning to their country of origin – and in
particular their motivations to cross these borders and visit
the IVF clinics in Ghana, provide insight into the structural
conditions impeding or facilitating the use of assisted
reproductive technologies at different local sites. In addi-
tion, their motivations and experiences with actual assisted
reproductive technologies in these clinics may reveal their
expectations about the sort of care, information and
attention they would like to receive.
Transnational movements also include the flow of ideas, as
was illustrated by the case of the Ghanaian woman who set up
an agency mediating between the needs of ‘wish parents’ and
donors and surrogates in Ghana, after having lived in the USA
for many years where she had become familiar with the idea of
surrogacy. While she initially acted out of self-interest (she
needed a surrogate for herself), she introduced new ideas and
cultural practices into Ghanaian society (Gerrits and Hörbst,
2016). Such intermediary agencies and their recruitment
practices, and the role they play in shaping and reshaping
cultural and societal notions, values and practices regarding,
for example, the essence of kinship, social and biological
parenthood and the importance of blood/genetic ties,
38 T Gerritsconstitute an area of anthropological study that is still
untouched in the sub-Saharan African context.
Finally, this article points to a number of thematic and
theoretical issues, which I believe require further explora-
tion in the anthropological study of assisted reproductive
technologies in general, and in Ghana in particular.
Following the introduction of tWE-IVF and examining its
effects – on couples and society – in Ghana and other
countries where it will be introduced is one of these themes.
Among others, it will be interesting to study how the tWE
initiative is received within the wider field of assisted
reproductive technology providers, as it may threaten the
interests of those who have already invested in costly
laboratory infrastructure (although it should be noted that
the tWE method does not replace ICSI and can certainly not
treat all fertility problems) (Johnson et al., 2014).
The functioning and impact of associations like the ACCOG
form another important subject for future studies. First of all,
it is important because lessons can be learned that may
improve the lives of infertile people in other settings. In
addition, it might be interesting to examine theoretically
how such associations create new types of ‘biological’ or
‘therapeutic’ citizens and introduce new ‘technologies of the
self’, when they promote the ‘coming out’ of infertile couples
and their engagement with counselling and self-help practices
(cf. Nguyen, 2010; Petryna, 2013).
The societal response – which includes the positioning of
the government and churches, but also the public at large – to
the use of assisted reproductive technologies, in particular
when it involves third parties, is an unexplored field, both in
Ghana and in sub-Saharan Africa in general. Analysing current
and past debates – as presented in the mass media, on the
internet and in policy documents –would help shedmore light
on the way in which assisted reproductive technologies are
received, perceived and contested in the country and the
region. Such insights will also provide an understanding of
present-day values and developments in Ghanaian society. In
sum – and at the risk of using a perhaps too clichédmetaphor–
the field of assisted reproductive technologies in Ghana
constitutes a barren terrain, waiting for anthropologists (and
other scholars) to plough and cultivate.
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